62 related articles for article (PubMed ID: 3533643)
21. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
Papamichael D
Oncologist; 1999; 4(6):478-87. PubMed ID: 10631692
[TBL] [Abstract][Full Text] [Related]
22. Acyclic analogues of 5-fluoro-dUMP and 5-fluoro-2'-deoxyuridine: synthesis and inhibition of thymidylate synthase and tumour cell growth.
Felczak K; Gołos B; Dzik JM; Rode W; Bretner M; Shugar D; Kulikowski T
Acta Biochim Pol; 1998; 45(1):75-82. PubMed ID: 9701498
[TBL] [Abstract][Full Text] [Related]
23. Thymidylate synthase inhibitors.
Ismail AS; Grem JL
Cancer Chemother Biol Response Modif; 2001; 19():1-19. PubMed ID: 11686010
[No Abstract] [Full Text] [Related]
24. [Inhibition of thymidylate synthase in chemotherapy].
Rode W
Postepy Biochem; 1996; 42(2):133-40. PubMed ID: 8805186
[No Abstract] [Full Text] [Related]
25. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.
Smith SG; Lehman NL; Moran RG
Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626
[TBL] [Abstract][Full Text] [Related]
26. Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agents.
Kirkpatrick DL; Watson S; Kunkel M; Fletcher S; Ulhaq S; Powis G
Anticancer Drug Des; 1999 Oct; 14(5):421-32. PubMed ID: 10766297
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
28. N4-hydroxy-5-halogeno-2'-deoxycytidine S and their 5'-mono-phosphates as inhibitors of thymidylate synthase and in vitro antileukemic agents.
Felczak K; Bretner M; Dzik JM; Gołos B; Zieliński Z; Rode W; Kulikowski T
Adv Exp Med Biol; 1998; 431():617-21. PubMed ID: 9598139
[No Abstract] [Full Text] [Related]
29. [Progress in the synthesis of new antitumor agents].
Wilman DE
Recenti Prog Med; 1984 Nov; 75(11):1034-56. PubMed ID: 6396748
[No Abstract] [Full Text] [Related]
30. Future challenges in the clinical development of thymidylate synthase inhibitor compounds.
Brandt DS; Chu E
Oncol Res; 1997; 9(8):403-10. PubMed ID: 9436193
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure based optimization of novel Akt inhibitors.
Lippa B; Pan G; Corbett M; Li C; Kauffman GS; Pandit J; Robinson S; Wei L; Kozina E; Marr ES; Borzillo G; Knauth E; Barbacci-Tobin EG; Vincent P; Troutman M; Baker D; Rajamohan F; Kakar S; Clark T; Morris J
Bioorg Med Chem Lett; 2008 Jun; 18(11):3359-63. PubMed ID: 18456494
[TBL] [Abstract][Full Text] [Related]
32. Alanine mutants of the interface residues of human thymidylate synthase decode key features of the binding mode of allosteric anticancer peptides.
Tochowicz A; Santucci M; Saxena P; Guaitoli G; Trande M; Finer-Moore J; Stroud RM; Costi MP
J Med Chem; 2015 Jan; 58(2):1012-8. PubMed ID: 25427005
[TBL] [Abstract][Full Text] [Related]
33. New anticancer agents.
Britten C; Hammond L; Hidalgo M; Rothenberg ML; Sharma A; Sharma S; Siu L; Villalona-Calero M; Weiss GR
Cancer Chemother Biol Response Modif; 1999; 18():178-209. PubMed ID: 10800483
[No Abstract] [Full Text] [Related]
34. Carbon-13 nuclear magnetic resonance of 5-substituted uracils.
Ellis PD; Dunlap RB; Pollard AL; Seidman K; Cardin AD
J Am Chem Soc; 1973 Jun; 95(13):4398-403. PubMed ID: 4708386
[No Abstract] [Full Text] [Related]
35. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets.
Nian S; Lo ACY; Mi Y; Ren K; Yang D
Eye Vis (Lond); 2021 May; 8(1):15. PubMed ID: 33931128
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of multisubstrate analog inhibitors of one-carbon transfer reactions.
Broom AD
Fed Proc; 1986 Nov; 45(12):2779-83. PubMed ID: 3533643
[TBL] [Abstract][Full Text] [Related]
37. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and evaluation of potent thymidylate synthase X inhibitors.
Esra Onen F; Boum Y; Jacquement C; Spanedda MV; Jaber N; Scherman D; Myllykallio H; Herscovici J
Bioorg Med Chem Lett; 2008 Jun; 18(12):3628-31. PubMed ID: 18513963
[TBL] [Abstract][Full Text] [Related]
40. Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family.
Ferrari S; Losasso V; Costi MP
ChemMedChem; 2008 Mar; 3(3):392-401. PubMed ID: 18270995
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
